In last trading session, Aspire Biopharma Holdings Inc (NASDAQ:ASBP) saw 1.6 million shares changing hands with its beta currently measuring 0.73. Company’s recent per share price level of $0.35 trading at $0.03 or 9.06% at ring of the bell on the day assigns it a market valuation of $17.17M. That closing price of ASBP’s stock is at a discount of -4414.29% from its 52-week high price of $15.80 and is indicating a premium of 37.14% from its 52-week low price of $0.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 8.83 million shares which gives us an average trading volume of 15.11 million if we extend that period to 3-months.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP) trade information

Upright in the green during last session for gaining 9.06%, in the last five days ASBP remained trading in the green while hitting it’s week-highest on Thursday, 07/10/25 when the stock touched $0.35 price level, adding 5.33% to its value on the day. Aspire Biopharma Holdings Inc’s shares saw a change of -96.94% in year-to-date performance and have moved 6.35% in past 5-day. Aspire Biopharma Holdings Inc (NASDAQ:ASBP) showed a performance of -5.14% in past 30-days. Number of shares sold short was 0.67 million shares which calculate 0.02 days to cover the short interests.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s Major holders

Insiders are in possession of 33.08% of company’s total shares while institution are holding 2.90 percent of that, with stock having share float percentage of 4.34%. Investors also watch the number of corporate investors in a company very closely, which is 2.90% institutions for Aspire Biopharma Holdings Inc that are currently holding shares of the company.